Men's Health

Latest News

Novel Antiobesity Drug Improves Body Composition, Bone Mineral Content in Phase 2 Study / image credit escape obesity: ©Siberian Art/stock.adobe.com
Novel Antiobesity Drug Significantly Improves Body Composition, Bone Mineral Content in Phase 2 Study

April 12th 2024

LPCN 2401, a combination anabolic androgen receptor agonist and α-tocopherol, decreased fat mass by 6.7% and increased lean mass by 4.4% over 36 weeks, said Lipocine, Inc.

Testosterone Replacement Does Not Increase Risk for CV Events in Men with Hypogonadism, New Study Finds  ©jarun011/stock.adobe.com
Testosterone Replacement Does Not Increase Risk for CV Events in Men with Hypogonadism, New Study Finds

June 20th 2023

alcoholic drink equivalent, drinking issues,
What, Exactly, is an Alcoholic Drink-equivalent?

April 15th 2023

Oral Superabsorbent Hydrogel Cuts Risk for Type 2 Diabetes
Daily Dose: Multimodal MRI Imaging Predicts Sex-specific Obesity Status

April 10th 2023

Podcasts
Latest CME Events & Activities

Earn CME Credits While Advancing Your Expertise in Internal Medicine

April 18-19, 2024

Register Now!

Medical Crossfire®: Updates in Continuous Glucose Monitoring—Having the Important Conversations With Your Patients

View More

Evaluating the Recent Advancements in Chronic Kidney Disease Treatment: A Case-Based Approach to Managing CKD and Related Comorbidities

View More

Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing

View More

Shaping the Management of COPD with Biologic Therapy

View More

Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease

View More

Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD

View More

Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis

View More

Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy

View More

Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy

View More

More News

© 2024 MJH Life Sciences

All rights reserved.